颈部处理:基于美国国家癌症数据库的临床淋巴结阴性声门上型鳞状细胞癌研究
该回顾性研究利用美国国家癌症数据库2019年参与者用户文件,分析1352例接受部分喉切除术的临床淋巴结阴性声门上型鳞状细胞癌患者,其中60%行择区性颈清扫,22%发现隐匿性淋巴结转移。择区性颈清扫在学术中心更常见,单因素分析显示其与总生存改善相关,但多因素分析无显著关联。
要点
- 临床淋巴结阴性声门上型鳞状细胞癌患者中22%存在隐匿性淋巴结转移
- 60%的患者接受了择区性颈清扫,40%未接受
- 择区性颈清扫在学术中心较非学术中心更常施行(OR 1.66)
核心结论
- 在cN0声门上型鳞状细胞癌接受部分喉切除术的患者中,22%存在隐匿性淋巴结转移,但40%未接受择区性颈清扫。
- 接受择区性颈清扫的患者更可能避免辅助放疗且不影响总生存。
研究设计与样本
- 回顾性研究,数据来源于美国国家癌症数据库2019年参与者用户文件。
- 纳入既往未治疗、临床淋巴结阴性、接受部分喉切除术的声门上型鳞状细胞癌患者,排除无颈部处理信息及行全喉切除术者,共1352例符合标准。
主要发现
- 811例(60%)行择区性颈清扫,其中177例(22%)发现隐匿性淋巴结转移。
- 学术中心较非学术中心更常行择区性颈清扫(比值比1.66,95%CI 1.32-2.09,P<.001)。
- 多因素分析中,接受辅助放疗者总生存更差(风险比1.45,95%CI 1.13-3.29,P=.017)。
- 单因素分析中择区性颈清扫与总生存改善相关(风险比0.83,95%CI 0.69-0.98,P=.026),但多因素分析中无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Identify the proportion of patients undergoing elective neck dissection (END) in surgically managed supraglottic squamous cell carcinoma (SCCa), assess associations between patient, tumor, and treatment factors with END, and assess associations between neck management and overall survival (OS). STUDY DESIGN: Retrospective study. SETTING: National Cancer Database (NCDB) 2019 Participant User File. METHODS: Patients with previously untreated, clinically node-negative (cN0) supraglottic SCCa treated with partial laryngectomy were queried from NCDB. Patients without known neck management and who underwent total laryngectomy were excluded. Patient and tumor factors associated with END were evaluated by logistic regression analysis. Univariable Cox proportional hazard analysis was used to examine associations between patient factors and OS, and factors with P < .05 were included on multivariable analysis. RESULTS: A total of 1352 patients met eligibility criteria. Eight hundred eleven (60%) patients had END performed with occult nodal metastasis identified in 177 (22%) patients. END was more likely to be performed at academic centers than nonacademic centers (odds ratio: [1.66], 95% confidence interval [CI]: 1.32-2.09, P < .001). On multivariable analysis, patients who underwent adjuvant radiation had worse OS (hazard ratio [HR]: 1.45, 95% CI: 1.13-3.29, P = .017). END was associated with improved OS overall on univariable analysis (HR: 0.83, 95% CI: 0.69-0.98, P = .026), but not on multivariable analysis. CONCLUSION: In this NCDB study, 22% of cN0 supraglottic SCCa patients had occult nodal metastatic disease. Despite this, 40% of patients do not receive END at the time of primary resection. Patients who receive END for supraglottic SCCa are more likely to avoid adjuvant radiation without impacting OS.
引用
- Barry E, Schmidt KL, Topf MC, et al. Addressing the Neck: An NCDB Study of Clinically Node-Negative Supraglottic Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2024. PMID: 39101350. doi:10.1002/ohn.932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。